Stockreport

BioDelivery Sciences International Completes Acquisition of ELYXYB™ for Acute Migraine Treatment in the U.S. and Canada

BioDelivery Sciences International, Inc.  (BDSI) 
Last biodelivery sciences international, inc. earnings: 11/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bdsi.com/news-events/news-releases
PDF Expands Portfolio and Establishes Growth Platform in Neurology The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine wi [Read more]